A single center, open-label, phase I/II study of two 90-microg doses of intramuscular inactivated influenza A/H5N1 vaccine in healthy adult subjects.
Phase of Trial: Phase I/II
Latest Information Update: 28 Aug 2008
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Pharmacodynamics
- 28 Aug 2008 Actual patient number (35) added as reported by ClinicalTrials.gov.
- 03 Jul 2008 Actual end date added (Dec 2006) as reported by ClinicalTrials.gov.
- 03 Jul 2008 Planned number of patients has been changed from 50 to 35 as reported by ClinicalTrials.gov.